The future of antibiotic catalysis lies in the integration of [synthetic biology]() and [metabolic engineering](). These fields aim to design and construct new biosynthetic pathways for antibiotic production in engineered microorganisms. By harnessing the power of catalysis, researchers can create more efficient and sustainable methods for producing existing antibiotics and discovering new ones. Additionally, the use of [nanocatalysts]() and [enzyme immobilization]() techniques could enhance the stability and reusability of catalytic systems in antibiotic synthesis.
